Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Articles published by Absci Corporation

< Previous 1 2 Next >
Absci to Participate in the TD Cowen 45th Annual Health Care Conference
From Absci Corporation
Via GlobeNewswire
Tickers ABSI
Absci to Participate in the Guggenheim Securities SMID Cap Biotech Conference
From Absci Corporation
Via GlobeNewswire
Tickers ABSI
Absci and AMD Announce Collaboration and Strategic Investment to Accelerate the Future of AI Drug Discovery
From Absci Corporation
Via GlobeNewswire
Tickers ABSI AMD
Absci to Participate in the 43rd Annual J.P. Morgan Healthcare Conference
From Absci Corporation
Via GlobeNewswire
Tickers ABSI
Absci Highlights Progress and Updates Across Proprietary Pipeline and Leading AI Platform at 2024 R&D Day
From Absci Corporation
Via GlobeNewswire
Tickers ABSI
Absci to Participate in the 36th Annual Piper Sandler Healthcare Conference
From Absci Corporation
Via GlobeNewswire
Tickers ABSI
Absci Reports Business Updates and Third Quarter 2024 Financial and Operating Results
From Absci Corporation
Via GlobeNewswire
Tickers ABSI
Absci to Host R&D Day on December 12, 2024
From Absci Corporation
Via GlobeNewswire
Tickers ABSI
Absci and Twist Bioscience Collaborate to Design Novel Antibody using Generative AI
From Absci Corporation
Via GlobeNewswire
Tickers ABSI TWST
Absci to Participate in Upcoming Investor Conferences
From Absci Corporation
Via GlobeNewswire
Tickers ABSI
Absci to Report Business Updates and Third Quarter 2024 Financial and Operating Results on November 12, 2024
From Absci Corporation
Via GlobeNewswire
Tickers ABSI
Absci to Participate in Upcoming Investor Conferences
From Absci Corporation
Via GlobeNewswire
Tickers ABSI
Absci Reports Business Updates and Second Quarter 2024 Financial and Operating Results
From Absci Corporation
Via GlobeNewswire
Tickers ABSI
Absci Collaborates with Global Cancer Center to Discover Novel Therapeutics Using Generative AI
From Absci Corporation
Via GlobeNewswire
Tickers ABSI
Absci to Report Business Updates and Second Quarter 2024 Financial and Operating Results on August 14, 2024
From Absci Corporation
Via GlobeNewswire
Tickers ABSI
Absci Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
From Absci Corporation
Via GlobeNewswire
Tickers ABSI
Absci to Participate in the Morgan Stanley 3rd Annual Life Sciences AI Summit
From Absci Corporation
Via GlobeNewswire
Tickers ABSI
Absci to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference
From Absci Corporation
Via GlobeNewswire
Tickers ABSI
Absci Reports Business Updates and First Quarter 2024 Financial and Operating Results
From Absci Corporation
Via GlobeNewswire
Tickers ABSI
Absci to Report Business Updates and First Quarter 2024 Financial and Operating Results on May 14, 2024
From Absci Corporation
Via GlobeNewswire
Tickers ABSI
Absci to Participate in the 23rd Annual Needham Virtual Healthcare Conference
From Absci Corporation
Via GlobeNewswire
Tickers ABSI
Absci Reports Business Updates and Fourth Quarter and Full Year 2023 Financial and Operating Results
From Absci Corporation
Via GlobeNewswire
Tickers ABSI
Absci Announces Closing of Public Offering of Common Stock Including Full Exercise of the Underwriters’ Option to Purchase Additional Shares
From Absci Corporation
Via GlobeNewswire
Tickers ABSI
Absci Announces Pricing of Public Offering of Common Stock
From Absci Corporation
Via GlobeNewswire
Tickers ABSI
Absci Announces Proposed Public Offering of Common Stock
From Absci Corporation
Via GlobeNewswire
Tickers ABSI
Absci Initiates IND-Enabling Studies for ABS-101, a Potential Best-in-Class Anti-TL1A Antibody de novo Designed and Optimized Using Generative AI
From Absci Corporation
Via GlobeNewswire
Tickers ABSI
Absci to Participate in Upcoming Investor Conferences
From Absci Corporation
Via GlobeNewswire
Tickers ABSI
Absci Appoints Professor Sir Mene Pangalos to its Board of Directors
From Absci Corporation
Via GlobeNewswire
Tickers ABSI
Absci to Present Preclinical Data for ABS-101, A Potential Best-in-Class Anti-TL1A Antibody Development Program, at 42nd Annual J.P. Morgan Healthcare Conference
From Absci Corporation
Via GlobeNewswire
Tickers ABSI
Absci to Participate in the 26th Annual Needham Growth Conference
From Absci Corporation
Via GlobeNewswire
Tickers ABSI
< Previous 1 2 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.